These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8637494)

  • 1. Does screening with prostate/specific antigen improve outcomes?
    Ohrt D
    Minn Med; 1996 Apr; 79(4):50-1. PubMed ID: 8637494
    [No Abstract]   [Full Text] [Related]  

  • 2. How valuable is prostate-specific antigen screening?
    Handler S
    Minn Med; 1996 Jun; 79(6):2. PubMed ID: 8692130
    [No Abstract]   [Full Text] [Related]  

  • 3. Prostate cancer screening: issues and controversies.
    O'Shaughnessy M; Konety B; Warlick C
    Minn Med; 2010 Aug; 93(8):39-44. PubMed ID: 20862878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PSA screening: the bottom line.
    Elhilali MM
    CMAJ; 2000 Mar; 162(6):791-2. PubMed ID: 10750466
    [No Abstract]   [Full Text] [Related]  

  • 5. [Mass screening for prostate cancer in Nagano].
    Ishizuka O; Satoh T; Kobayashi S; Nishizawa O
    Hinyokika Kiyo; 2001 Nov; 47(11):769-72. PubMed ID: 11771167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Best screening tests for prostate cancer.
    Moul JW
    West J Med; 1998 Aug; 169(2):109-10. PubMed ID: 9735692
    [No Abstract]   [Full Text] [Related]  

  • 7. Controversy over prostate-specific antigen screening has shifted from mortality to overtreatment issues.
    Ito K
    Int J Urol; 2009 Sep; 16(9):711-12. PubMed ID: 19777638
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy vs effectiveness in prostate-specific antigen screening.
    Albertsen PC
    J Natl Cancer Inst; 2010 Mar; 102(5):288-9. PubMed ID: 20142583
    [No Abstract]   [Full Text] [Related]  

  • 9. Why PSA testing does have value.
    Kirby M
    Practitioner; 1997 Jul; 241(1576):363. PubMed ID: 9425708
    [No Abstract]   [Full Text] [Related]  

  • 10. Early detection of prostate cancer. Decreasing the mortality rate.
    Oesterling JE
    Minn Med; 1996 Apr; 79(4):46-9. PubMed ID: 8637492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is an improved PSA screening test in sight?
    Savage L
    J Natl Cancer Inst; 2007 Oct; 99(20):1503-4. PubMed ID: 17925529
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact of prostate-specific antigen screening on the natural history of prostate cancer.
    Rosen MA
    Urology; 1995 Dec; 46(6):757-68. PubMed ID: 7502411
    [No Abstract]   [Full Text] [Related]  

  • 13. Screening by the prostate-specific antigen test: what do the patients know?
    Diefenbach PN; Ganz PA; Pawlow AJ; Guthrie D
    J Cancer Educ; 1996; 11(1):39-44. PubMed ID: 8777154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The use of prostate specific antigen in prostate cancer--prediction for treatment failure].
    Egawa S
    Nihon Rinsho; 2002 Dec; 60 Suppl 11():100-6. PubMed ID: 12599553
    [No Abstract]   [Full Text] [Related]  

  • 15. [The PSA test does not hold for screening. Good--but not good enough].
    Holmström B; Johansson M; Bratt O; Stattin P
    Lakartidningen; 2010 Feb 17-23; 107(7):436, 438-9. PubMed ID: 20384076
    [No Abstract]   [Full Text] [Related]  

  • 16. [Serum prostate specific antigen for the early detection of prostate cancer in outpatients of internal medicine].
    Otani T; Hayashi Y; Ikuno Y; Hirao Y; Ozono S; Okajima E
    Hinyokika Kiyo; 1996 Sep; 42(9):645-9. PubMed ID: 8918662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate cancer: 4. Screening.
    Meyer F; Fradet Y
    CMAJ; 1998 Oct; 159(8):968-72. PubMed ID: 9834724
    [No Abstract]   [Full Text] [Related]  

  • 18. [Mass screening for prostate cancer will have to wait. The scientific basis insufficient, more efficient markers necessary].
    Damber JE
    Lakartidningen; 2003 Sep; 100(38):2916-8, 2921. PubMed ID: 14558209
    [No Abstract]   [Full Text] [Related]  

  • 19. Lead time of prostate cancer detected in population based screening for prostate cancer in Japan.
    Ito K; Yamamoto T; Miyakubo M; Takechi H; Ohi M; Shibata Y; Suzuki K
    J Urol; 2007 Oct; 178(4 Pt 1):1258-63; discussion 1263-4. PubMed ID: 17698107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate cancer: enthusiasm for screening.
    Kaye KW
    Med J Aust; 1995 May; 162(10):540-1. PubMed ID: 7539884
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.